Home
Conditions
Muscular Dystrophy, Duchenne

Clinical trial condition

Muscular Dystrophy, Duchenne

Explore clinical trials studying Muscular Dystrophy, Duchenne. Study availability and eligibility vary by location and protocol.

357 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Muscular Dystrophy, Duchenne trial results

Enrolling by Invitation

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

NCT02413450

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +46 more
Locations: Johns Hopkins Medical Institute Baltimore, Maryland, United States

View Trial Details

Enrolling by Invitation

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

NCT06606340

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations: Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States

Children's Hospital Los Angeles Los Angeles, California, United States

University of California Davis Medical Center Sacramento, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

View all 20 locations

View Trial Details

Enrolling by Invitation

Follow-up Study on Female Carriers With DMD Gene Variants

NCT05715957

Conditions: Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +10 more
Locations: Copenhagen neuromuscular center Copenhagen, Denmark

View Trial Details

Enrolling by Invitation

Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.

NCT06363526

Conditions: Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +10 more
Locations: Rocío Martín-Valero Málaga, Spain

View Trial Details

Enrolling by Invitation

Psychoeducation Program for Parents of Children with Duchenne Muscular Dystrophy

NCT06412328

Conditions: Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +14 more
Locations: Lokman Hekim Universiyt Ankara, Cankaya, Turkey (Türkiye)

View Trial Details

Not Yet Recruiting

Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy

NCT07704099

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

NCT07587242

Conditions: Congenital, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, +22 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)

NCT07682129

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations: University Hospital Gent Ghent, Belgium

UZ Leuven Leuven, Belgium

Centre Hospitalier Régional de la Citadelle Liège, Belgium

IRCCS Ospedale San Raffaele Milan, Italy

View all 17 locations

View Trial Details

Not Yet Recruiting

Digital Monitoring of Upper Limb Function in Non-Ambulant DMD

NCT07664124

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations: Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle Liège, Belgium

View Trial Details

Not Yet Recruiting

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

NCT07642635

Conditions: Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), +16 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Muscular Dystrophy, Duchenne

Muscular Dystrophy, Duchenne trial results

Related conditions